Writing |Wang Hang
Source | “Medical Community” Public Account
Academician Ge Junbo never said much about his achievements and honors. In his opinion, as a clinician, curing the disease and improving the quality of life for patients is the highest pursuit, and therefore, he has never stopped pursuing progress.
Member of the National Committee of the Chinese People’s Political Consultative Conference, Academician of Chinese Academy of Sciences, Vice Chairman of Shanghai Municipal Committee of Jiusan Society, Director of Cardiology Department of Zhongshan Hospital Affiliated to Fudan University, President of Cardiovascular Branch of Chinese Medical Doctor Association, President of Anhui Provincial Hospital , Director of Shanghai Institute of Cardiovascular Diseases…
Academician Ge Junbo, who is well-known in the academic world, has many titles, but among many roles, the one he cherishes most is a doctor. “Actually, I am a clinical doctor, so that patients can recover faster and undergo surgery with less trauma, and ultimately help patients return to society, family, and life with more dignity.”
Driven by this original intention, he has been rooted in the field of cardiovascular disease for 40 years. He has led the team to continuously achieve breakthroughs, promoted the innovation of clinical technology and the transformation of scientific research results in China’s cardiovascular disease, and created many “The first case in the country” and “the first in Shanghai” in the diagnosis and treatment of heart disease.
Academician Ge Junbo has been running around for the prevention and treatment of cardiovascular diseases in China and the promotion of the concept of value medical care. He has a wish that one day in the future, the core technology of clinical diagnosis and treatment and medical equipment will be in the hands of the Chinese.
Ge Junbo, Academician of the Chinese Academy of Sciences, Director of the Department of Cardiology, Zhongshan Hospital Affiliated to Fudan University
From being famous overseas to returning home
Academician Ge Junbo suffered a fracture at the age of 11 and was cured by a doctor in his hometown. In the future, he talked about this experience many times to the outside world, and the career choice and ideal of being a doctor and treating diseases and saving people were established.
He grew up in a peasant family in Wulian County, Shandong Province, and has been the top student in his class since he started elementary school at the age of 6. In 1977, Ge Junbo, who had just entered the first year of senior high school, ushered in a turning point in his fate – China announced the resumption of the college entrance examination.
Academician Ge Junbo at a young age
At the age of 16, as the third batch of candidates after the resumption of the college entrance examination, and one of the only three college students in Wulian County, Ge Junbo was successfully admitted to Qingdao Medical College. After that, as one of the 4 students admitted to the postgraduate course among the 75 college students in the same year, he entered Shandong Medical University to study for a master’s degree in clinical medicine with the first place in 1984.
During his master’s degree, Junbo Ge’s research direction was pediatric congenital heart disease. According to his recollection, at that time, many children from rural areas were often too late to seek medical treatment because they failed to receive medical treatment in time. Coupled with the limited medical level, the mortality rate of children was relatively high. This phenomenon touched him very much, and he was determined to continue his academic studies.
He “has been in the habit of getting up at 4 a.m. to read for more than a decade.” With talent and diligence, this young farmer from Shandong got his Ph.D. degree all the way. After he received his Ph.D. from Shanghai Medical University in 1990, he was sent to the Medical School of Mainz University in Germany for further study. Three years later, he was engaged in postdoctoral research at the Medical School of Essen University.
During his studies and work in Germany, his achievements were highly recognized by his tutors. Ge Junbo was in his early 30s when he obtained a German medical license and became the director of the intravascular ultrasound room of the Department of Cardiology at the University of Essen Medical School. At that time, ultrasound technology was very mature in the field of medical diagnosis, but the application of ultrasound probes into blood vessels for diagnosis was still in its infancy, and this was one of Ge Junbo’s work.
One weekend in 1997, he came to the Cardiology Laboratory as usual to analyze the data, a hypoechoic or anechoic half-moon on the intravascular ultrasound image of a patient with myocardial bridge. Ou came into his field of vision, and by reviewing the ultrasound images of all myocardial bridge patients in the laboratory, Ge Junbo found that the images of each myocardial bridge patient had a similar “half-moon phenomenon”.
Before this time, myocardial ischemia caused by myocardial bridges and myocardial ischemia caused by coronary atherosclerotic stenosis were very similar in symptoms, but treated differently. How to accurately distinguish these two diseases has always been a difficult problem in the industry.
Ge Junbo’s discovery has greatly improved the diagnostic rate of myocardial bridges, increasing the detection rate from less than 5% to more than 95%. The “half-moon phenomenon” on intravascular ultrasound images has been It has become the internationally accepted diagnostic criteria for myocardial bridges. This achievement is also known as “Gurd’s phenomenon”, and the famous European cardiovascular expert Professor Sanchez (Sanchez) called it “the pioneer of the application of intravascular ultrasound to detect myocardial bridges”.
Nine in GermanyIn the past year, Ge Junbo has achieved a lot and published more than 200 academic papers. Recalling this experience, he always said: “It was a rare time to concentrate on research, young, energetic, without chores, and without distractions.”
On April 25, 1999, when many honors and opportunities came, Ge Junbo chose to retire bravely, ended his 10-year study and work in Germany, and returned to Shanghai to become a The first batch of Changjiang Scholars contributed to the development of medicine in the motherland.
In the year of returning to China, Ge Junbo was only 37 years old, and served as the deputy director of the Department of Cardiology, the director of the Cardiac Catheterization Department of Zhongshan Hospital Affiliated to Fudan University, and the deputy director of the Shanghai Institute of Cardiovascular Diseases. At the same time, he brought back his world-class cardiovascular disease diagnosis and treatment technology.
Create multiple heart disease treatments
“First in China” and “First in Shanghai”
Academician Ge Junbo recalled that when he first returned to China, although everything went well on the surface, he experienced many unknown ordeals.
Because of his “foreign” status, he was not favored by his colleagues at first. Most people think that he can publish English papers, kill guinea pigs, and do experiments, but his clinical performance is difficult to say. . On the first Spring Festival vacation after returning to China, he spent it alone in the office, eating instant noodles while writing the fund summary report.
The breakout comes after several major surgeries. When performing operations such as intubation, Ge Junbo perfectly realized the work that should have been done by the anesthesiologist, and some thorny illnesses also turned the corner in his hands. Colleagues began to discover that Ge Junbo could not only cure diseases that others could not cure, but also problems that others could not. In just half a year, he was respected and recognized by colleagues and patients.
Under the active promotion of Ge Junbo, in the second year after returning to China, the first heart transplant operation in Zhongshan Hospital was a great success with the cooperation of multiple departments such as cardiac surgery and cardiology. Today, the heart transplant operation at Zhongshan Hospital has become a national model.
With the focus on medical research, Academician Ge Junbo led the team to overcome one problem after another, creating a number of “first cases in China” and “first cases in Shanghai” in the diagnosis and treatment of heart disease: Intravascular ultrasound, retrograde wire technique, degradable stent, heart valve implantation…
Academician Ge Junbo
October 20, 2005 is a special day for Academician Ge Junbo. On this day, at the Transcatheter Cardiovascular Therapy (TCT) conference, for the first time, he broadcasted the surgical cases of the cardiac catheterization room of Zhongshan Hospital-Venticular Septal Defect and Left Main Coronary Artery via satellite to the main venue in Washington, USA for the first time. Chronic Total Occlusion” (CTO) surgery, which is also the first time that a Chinese surgery was broadcast to the TCT conference site in the United States.
Among them, CTO lesions are the most noticeable. When he introduced the patient’s coronary angiography results, all the audience in the main venue expressed great interest in this extremely challenging operation, and there were also some doubtful eyes – the CTO lesion was coronary intervention at that time. difficulties in.
During the operation, he took the lead in adopting the “reverse wire technique” in the world to further improve the success rate of coronary chronic total occlusion lesions, which was highly praised by his colleagues in the United States. The success of the live broadcast to the United States made him so excited that he couldn’t sleep at night.
Academician Ge Junbo during surgery
If the “half-moon phenomenon” is just his accidental fame in the world, a series of technological breakthroughs after returning to China are enough to prove Ge Junbo’s medical strength. On October 3, 2010, Ge Junbo successfully completed the first “percutaneous aortic valve replacement surgery” in my country, writing a new chapter for the history of cardiac intervention in China. Two years later, he successfully completed the first “percutaneous mitral valve repair” in China.
Under his leadership, one after another international and domestic “first”, “first” and “leading” medical achievements have been created, constantly refreshing the medical history of China.
Live up to my life,
Advocate and practice value healthcare
Academician Ge Junbo has never said much about the achievements and honors he has made. In his opinion, as a clinician, treating patients’ diseases and improving the quality of life is the highest pursuit. Therefore, he never stopped pursuing progress.
In recent years, the concept of “value medical care” has been frequently mentioned by him. In his view, “Whether it is medical devices, drugs, treatment methods, etc., the original intention and goal must be patient-centered, and ultimately maximize the interests of patients.”
In order to enable more patients to obtain the most cost-effective diagnosis and treatment services, Academician Ge Junbo was elected as the chairman of the selection and management committee of the “Value Medical Taishan Award” last year, and joined hands with the “medical community” to help Chinese medical care will soon move towards a new era of “patient-centered”.
Academician Ge Junbo delivered a speech at the “Third Value Healthcare Taishan Award Ceremony”
“The purpose of medicine is not only to prolong the life of the patient, but also to relieve the suffering of the patient, so that the patient can return to the family, life and society with dignity. No one can live forever. Hence the ‘Tarzan Award’ It not only embodies the responsibility of doctors, but also interprets the Taishan spirit of being brave in pioneering. It is necessary to make the blood of those who have won the award excited, and let those who have not won the award have a direction to pursue, so that everyone yearns for this award.”
He hopes that one day, the “Taishan Award” will become the wind vane of China’s medical value, and even the “Nobel Prize” in China’s medical field.
“Under the impetus of the epidemic, life sciences and medical health have been further integrated, and some new technologies and new drugs have been accelerated to enter the clinic. Some value-oriented medical concepts should be seen and respected. Ultimately, it becomes a medical service that brings dignity, physical and mental satisfaction and health to patients.”
In clinical and scientific research, Academician Ge Junbo has always done this.
Twenty years ago, when cardiac stents depended on imports and were expensive, he included the localization of drug stents as one of his clinical research topics, and in 2005, he led the development of ” A Novel Degradable Coated Coronary Drug-Eluting Stent”. After preliminary estimates, this achievement can save up to 1.2 billion yuan in medical expenses for patients and the country every year.
From my country’s first degradable coated coronary stent to the international original arsenic trioxide drug stent, to the first bioabsorbable coronary stent, Academician Ge Junbo has been working hard to make the common people use it. Affordable, good use.
He also repeatedly emphasized to the “medical community” that “the patient should be viewed as a whole, not treated in sections.” In response to the increasingly severe prevention and control situation of cardiovascular diseases, in 2015, he proposed the concept of “pan-vascular medicine” for the first time in China to prevent the occurrence of vascular diseases from the source.
In 2019, Academician Ge Junbo led the publication of the “Scientific Statement on the Prevention and Treatment of Panvascular Diseases”, which proposed to change the current prevention and treatment model of “disease-centered” and “clinical event-centered”. The prevention and treatment strategy of panvascular diseases should adhere to the all-round and full-cycle management concepts of “patient-centered” and “health promotion-centered”.
In the national “14th Five-Year Plan”, pan-vascular disease is included in the major research plan, and experts from cardiovascular, endocrinology, kidney disease and other disciplines are jointly Intervention, diagnosis, treatment and rehabilitation of the main upstream diseases. The Panvascular Disease Management Center initiated by him has attracted widespread attention in the cardiovascular field, opening a new paradigm and role model for chronic disease management.
Academician Ge Junbo never intends to “slow down”, and is always on the operating table, department, and scientific research. He has not rested for many years. No matter how many positions he holds or how many honors he has won, he always repeats one sentence: “I am not a doctor, but a clinical doctor.”
A great story you want to see
Doctor Station”Character Interview” column has
DownloadDoctor Station App, subscribe anytime, anywhere~
Proofreading: Zang Hengjia
Editor in charge: Tian Dongliang
Hot text recommendations
* The medical community strives for the accuracy and reliability of its published content when it is reviewed and approved, but does not regard the timeliness of the published content, and the accuracy and completeness of the cited materials (if any), etc. Make any promises and guarantees, and do not assume any responsibility for the outdated content, possible inaccuracy or incompleteness of the cited information. Relevant parties are requested to check separately when adopting or using it as a basis for decision-making.